Cefepime versus ceftazidime: considerations for empirical use in critically ill patients

MLA

Roberts, Jason A., et al. “Cefepime versus Ceftazidime: Considerations for Empirical Use in Critically Ill Patients.” International Journal of Antimicrobial Agents, vol. 29, no. 2, Feb. 2007, pp. 117–28. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2006.08.031.

APA

Roberts, J. A., Webb, S. A. R., & Lipman, J. (2007). Cefepime versus ceftazidime: considerations for empirical use in critically ill patients. International Journal of Antimicrobial Agents, 29(2), 117–128. https://doi.org/10.1016/j.ijantimicag.2006.08.031

Chicago

Roberts, Jason A., Steven A.R. Webb, and Jeffrey Lipman. 2007. “Cefepime versus Ceftazidime: Considerations for Empirical Use in Critically Ill Patients.” International Journal of Antimicrobial Agents 29 (2): 117–28. doi:10.1016/j.ijantimicag.2006.08.031.